Patent 11118226 was granted and assigned to Agilent Technologies on September, 2021 by the United States Patent and Trademark Office.
The invention provides methods and compositions for hybridizing at least one molecule to a target. The invention may, for example, utilize a of cyclic and/or non-cyclic solvent that is non-toxic and may eliminate or reduce the amount of formamide in the hybridization composition.